Cargando…

Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis

Diabetes mellitus is associated with cardiovascular disease and cardiac arrhythmia. Accumulation of advanced glycation end products closely correlates with cardiovascular complications through mitochondrial dysfunction or oxidative stress and evoke proliferative, inflammatory, and fibrotic reactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yao‐Chang, Lu, Yen‐Yu, Wu, Wen‐Shiann, Lin, Yung‐Kuo, Chen, Yi‐Ann, Chen, Shih‐Ann, Chen, Yi‐Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630757/
https://www.ncbi.nlm.nih.gov/pubmed/36325589
http://dx.doi.org/10.14814/phy2.15499
_version_ 1784823676081799168
author Chen, Yao‐Chang
Lu, Yen‐Yu
Wu, Wen‐Shiann
Lin, Yung‐Kuo
Chen, Yi‐Ann
Chen, Shih‐Ann
Chen, Yi‐Jen
author_facet Chen, Yao‐Chang
Lu, Yen‐Yu
Wu, Wen‐Shiann
Lin, Yung‐Kuo
Chen, Yi‐Ann
Chen, Shih‐Ann
Chen, Yi‐Jen
author_sort Chen, Yao‐Chang
collection PubMed
description Diabetes mellitus is associated with cardiovascular disease and cardiac arrhythmia. Accumulation of advanced glycation end products closely correlates with cardiovascular complications through mitochondrial dysfunction or oxidative stress and evoke proliferative, inflammatory, and fibrotic reactions, which might impair cardiac electrophysiological characteristics and increase the incidence of cardiac arrhythmia. This study examined the mechanisms how advanced glycation end products may contribute to arrhythmogenesis of right ventricular outflow tract—a unique arrhythmogenic substrate. A whole‐cell patch clamp, conventional electrophysiological study, fluorescence imaging, Western blot, and confocal microscope were used to study the electrical activity, and Ca(2+) homeostasis or signaling in isolated right ventricular outflow tract myocytes with and without advanced glycation end products (100 μg/ml). The advanced glycation end products treated right ventricular outflow tract myocytes had a similar action potential duration as the controls, but exhibited a lower L‐type Ca(2+) current, higher late sodium current and transient outward current. Moreover, the advanced glycation end products treated right ventricular outflow tract myocytes had more intracellular Na(+), reverse mode Na(+)–Ca(2+) exchanger currents, intracellular and mitochondrial reactive oxygen species, and less intracellular Ca(2+) transient and sarcoplasmic reticulum Ca(2+) content with upregulated calcium homeostasis proteins and advanced glycation end products related signaling pathway proteins. In conclusions, advanced glycation end products modulate right ventricular outflow tract electrophysiological characteristics with larger late sodium current, intracellular Na(+), reverse mode Na(+)–Ca(2+) exchanger currents, and disturbed Ca(2+) homeostasis through increased oxidative stress mediated by the activation of the advanced glycation end products signaling pathway.
format Online
Article
Text
id pubmed-9630757
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96307572022-11-07 Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis Chen, Yao‐Chang Lu, Yen‐Yu Wu, Wen‐Shiann Lin, Yung‐Kuo Chen, Yi‐Ann Chen, Shih‐Ann Chen, Yi‐Jen Physiol Rep Original Articles Diabetes mellitus is associated with cardiovascular disease and cardiac arrhythmia. Accumulation of advanced glycation end products closely correlates with cardiovascular complications through mitochondrial dysfunction or oxidative stress and evoke proliferative, inflammatory, and fibrotic reactions, which might impair cardiac electrophysiological characteristics and increase the incidence of cardiac arrhythmia. This study examined the mechanisms how advanced glycation end products may contribute to arrhythmogenesis of right ventricular outflow tract—a unique arrhythmogenic substrate. A whole‐cell patch clamp, conventional electrophysiological study, fluorescence imaging, Western blot, and confocal microscope were used to study the electrical activity, and Ca(2+) homeostasis or signaling in isolated right ventricular outflow tract myocytes with and without advanced glycation end products (100 μg/ml). The advanced glycation end products treated right ventricular outflow tract myocytes had a similar action potential duration as the controls, but exhibited a lower L‐type Ca(2+) current, higher late sodium current and transient outward current. Moreover, the advanced glycation end products treated right ventricular outflow tract myocytes had more intracellular Na(+), reverse mode Na(+)–Ca(2+) exchanger currents, intracellular and mitochondrial reactive oxygen species, and less intracellular Ca(2+) transient and sarcoplasmic reticulum Ca(2+) content with upregulated calcium homeostasis proteins and advanced glycation end products related signaling pathway proteins. In conclusions, advanced glycation end products modulate right ventricular outflow tract electrophysiological characteristics with larger late sodium current, intracellular Na(+), reverse mode Na(+)–Ca(2+) exchanger currents, and disturbed Ca(2+) homeostasis through increased oxidative stress mediated by the activation of the advanced glycation end products signaling pathway. John Wiley and Sons Inc. 2022-11-02 /pmc/articles/PMC9630757/ /pubmed/36325589 http://dx.doi.org/10.14814/phy2.15499 Text en © 2022 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Chen, Yao‐Chang
Lu, Yen‐Yu
Wu, Wen‐Shiann
Lin, Yung‐Kuo
Chen, Yi‐Ann
Chen, Shih‐Ann
Chen, Yi‐Jen
Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
title Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
title_full Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
title_fullStr Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
title_full_unstemmed Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
title_short Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
title_sort advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: a novel target for diabetes‐related ventricular arrhythmogenesis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630757/
https://www.ncbi.nlm.nih.gov/pubmed/36325589
http://dx.doi.org/10.14814/phy2.15499
work_keys_str_mv AT chenyaochang advancedglycationendproductsmodulateelectrophysiologicalremodelingofrightventricularoutflowtractcardiomyocytesanoveltargetfordiabetesrelatedventriculararrhythmogenesis
AT luyenyu advancedglycationendproductsmodulateelectrophysiologicalremodelingofrightventricularoutflowtractcardiomyocytesanoveltargetfordiabetesrelatedventriculararrhythmogenesis
AT wuwenshiann advancedglycationendproductsmodulateelectrophysiologicalremodelingofrightventricularoutflowtractcardiomyocytesanoveltargetfordiabetesrelatedventriculararrhythmogenesis
AT linyungkuo advancedglycationendproductsmodulateelectrophysiologicalremodelingofrightventricularoutflowtractcardiomyocytesanoveltargetfordiabetesrelatedventriculararrhythmogenesis
AT chenyiann advancedglycationendproductsmodulateelectrophysiologicalremodelingofrightventricularoutflowtractcardiomyocytesanoveltargetfordiabetesrelatedventriculararrhythmogenesis
AT chenshihann advancedglycationendproductsmodulateelectrophysiologicalremodelingofrightventricularoutflowtractcardiomyocytesanoveltargetfordiabetesrelatedventriculararrhythmogenesis
AT chenyijen advancedglycationendproductsmodulateelectrophysiologicalremodelingofrightventricularoutflowtractcardiomyocytesanoveltargetfordiabetesrelatedventriculararrhythmogenesis